{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-032784","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.808741+00:00","generated_at":"2026-05-30T07:17:41.749057+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LeMaitre Vascular Q3 sales up 16% to $54.8M, EPS $0.49 (+46%), raises full-year guidance","bullets":["Q3 sales $54.8M (+16% organic); diluted EPS $0.49, +46% YoY.","Gross margin 67.8% (+280 bps) on price increases and manufacturing efficiencies.","Full-year guidance raised: sales $219-221M, op margin 24%, EPS $1.91-1.96.","Quarterly dividend of $0.16/share declared, payable Dec 5 to holders of record Nov 21.","Cash increased $10.8M sequentially to $123.9M; $50M share repurchase program ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-032784","json":"https://secwatch.observer/filing/0001437749-24-032784.json","markdown":"https://secwatch.observer/filing/0001437749-24-032784.md","text":"https://secwatch.observer/filing/0001437749-24-032784.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774924032784/0001437749-24-032784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774924032784/lmat20241031_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:17:41.749057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}